[Toxicological characteristics of a new collagen-based pyromecaine ointment].
D000707:Anaphylaxis / Q000139:chemically induced; D000779:Anesthetics, Local / Q000276:immunology / Q000633:toxicity*; D000818:Animals; D002594:Cetylpyridinium / Q000276:immunology / Q000633:toxicity*; D003094:Collagen / Q000276:immunology / Q000633:toxicity*; D004338:Drug Combinations / Q000276:immunology / Q000633:toxicity; D006168:Guinea Pigs; D007928:Lethal Dose 50; D009823:Ointment Bases; D009824:Ointments; D011726:Pyridinium Compounds / Q000633:toxicity*; D011759:Pyrrolidines / Q000276:immunology / Q000633:toxicity*; D011817:Rabbits; D051381:Rats; D013997:Time Factors; D014498:Uracil / Q000031:analogs & derivatives* / Q000276:immunology / Q000633:toxicity
D000779:Anesthetics, Local; D004338:Drug Combinations; D009823:Ointment Bases; D009824:Ointments; D011726:Pyridinium Compounds; D011759:Pyrrolidines; C000661:bumecain; D014498:Uracil; D003094:Collagen; D002594:Cetylpyridinium
Toksikologicheskaia kharakteristika novoĭ piromekainovoĭ mazi na osnove kollagena.